Module overview
Section 4 of 6 · Open sections

Required section · Section 4 of 6

Work the result set in time order

At 09:05, the technologist verifies identifiers, K2EDTA collection time, specimen acceptability, analyzer quality-control status, and smear/stain quality. A systematic scan confirms the CBC pattern, blast-like cells, Auer rods, and an abnormal promyelocyte-rich field. The technologist documents the observable evidence and obtains the local qualified second review or escalation as required; neither action turns the finding into a final diagnosis.

Urgent communication and allocation occur in parallel. While the locally defined urgent pathway is called, a suitable unfixed, viable aliquot is routed under the local acute-leukemia procedure to flow cytometry and conventional cytogenetics, with material retained or routed for FISH, molecular testing, and rapid testing for PML::RARA, the defining fusion of APL, as locally validated. The technologist records specimen type, anticoagulant, volume, stability, viability when required, transport conditions, time, destination, and any limitation rather than assuming every assay can use the remaining material.

Fibrinogen 92 mg/dL, prothrombin time 18.8 seconds, and international normalized ratio 1.6 are APL-associated coagulopathy correlation data in this morphology context. Potassium 4.8 mmol/L, creatinine 1.0 mg/dL, uric acid 7.9 mg/dL, phosphorus 4.4 mg/dL, and lactate dehydrogenase 1320 U/L are tumor-lysis chemistry context. These are separate urgent processes: coagulation testing and rapid PML::RARA testing address suspected APL, whereas serial metabolic evaluation is used for tumor-lysis assessment under local and clinical pathways. Neither set establishes leukemia subtype or treatment thresholds.

The laboratory releases only components that meet validated release criteria; it holds or suppresses components that require review under its procedure, and performs or reports a manual differential only when indicated and validated. A BLAST? flag does not by itself dictate that every CBC component be held, and a manual differential does not confirm subtype. Notification documentation includes the recipient, time, result or concern communicated, and read-back when required. Protect viable material and make the urgent call without delaying either for final classification.

Illustrative drawing — this picture was drawn rather than captured.

Allocation board requires checks of specimen type, anticoagulant, volume, stability, viability when needed, and transport before routing. It separates a morphology slide from retaining viable unfixed cells, gives method-specific flow, cytogenetics, FISH, molecular, and rapid PML::RARA routes, and shows urgent notification in parallel.
Figure 1Slide preparation, viable-cell retention, method-specific allocation, and concurrent urgent communication are distinct operational actions.
APL-coagulopathy and tumor-lysis context: stated local-status examples are separate correlations, not subtype confirmation
AnalyteValueStatus / interpretive boundary
Fibrinogen92 mg/dLBelow the local reference interval in this scenario; APL-associated coagulopathy correlation, not PML::RARA confirmation
PT18.8 sAbove the local reference interval in this scenario; APL-associated coagulopathy correlation, not PML::RARA confirmation
INR1.6Above the local reference interval in this scenario; APL-associated coagulopathy correlation, not PML::RARA confirmation
Potassium4.8 mmol/LTumor-lysis chemistry context; compare with the local interval and assess serially under local and clinical pathways
Creatinine1.0 mg/dLTumor-lysis chemistry context; compare with the local interval; one value does not exclude risk
Uric acid7.9 mg/dLTumor-lysis chemistry context; compare with the local interval; not APL confirmation
Phosphorus4.4 mg/dLTumor-lysis chemistry context; compare with the local interval; not APL confirmation
LDH1320 U/LTumor-lysis chemistry context; compare with the local interval; not APL confirmation

Knowledge checks

Reading and checks are open. Sign in only to save.

Knowledge check 1

Which statements correctly separate the urgent contexts in the guided case? Select all that apply.

Choose at least 3 options.

Knowledge check 2

After systematic smear review identifies the urgent concern, which operational approach is appropriate before a final subtype is assigned?

Choose one option.

Section status

Finish this section

Reading and checks are open. Sign in only to save.

The module finishes after every required section is marked done and every check in those sections is correct.